Rating History for Entrada Therapeutics (TRDA) by Oppenheimer

More Stocks Rated by Oppenheimer | Latest Ratings for TRDA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/28/2026 Hartaj Singh New Coverage Outperform
(N/A)		 21.00
(N/A)		 11.00
(12.58)		 14.36% Details